CTVANYSEAgricultural Production-CropsUS GAAP · USD

Corteva, Inc.

Corteva, Inc. develops and sells seed and crop protection products for farmers and agricultural distributors worldwide. Its portfolio spans genetically improved seeds, herbicides, fungicides, insecticides, and related biotechnology traits, with heavy reliance on regulatory approvals and intellectual property protection.

Revenue17.4bn USD
+2.9 %y/y
Net income1,094m USD
+20.6 %y/y
Free cash flow3,406m USD
+58.8 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

05101520bn USD2020: 14.2 bn USD20202021: 15.7 bn USD20212022: 17.5 bn USD20222023: 17.2 bn USD20232024: 16.9 bn USD20242025: 17.4 bn USD202517.4
RevenueOperating profit (EBIT)

Business

Share of revenue
Seed55 %

Genetically improved seeds and trait technologies sold to improve yield, resilience and farm productivity.

Crop Protection45 %

Herbicides, fungicides, insecticides and other crop protection chemistries used to protect crops and manage pests.

Customers

Corteva sells primarily to commercial farmers, farm cooperatives, and agricultural distributors that need higher-yield seed genetics and effective crop protection tools. Demand is tied to planting decisions, pest pressure, weather, and crop economics, so customers buy to improve productivity and protect harvest outcomes. The company also serves channel partners and distributors that aggregate demand and provide local agronomic support.

Commercial farmers

Buy seed, traits and crop protection products to maximize yield and manage pests, weeds and disease.

Agricultural distributors and cooperatives

Purchase products for resale and provide local agronomy, financing and logistics to end growers.

Large row-crop growers

Buy higher-value traited seed and herbicide programs for corn, soybean and other broad-acre crops.

International growers

Buy crop protection and seed products adapted to local regulatory regimes and crop conditions.

Strategy

Corteva is focused on improving its seed and crop protection portfolio through R&D, regulatory approvals and product lifecycle management. Management is also emphasizing cost and productivity actions, working capital discipline and liquidity management while preparing for a planned separation of the seed and crop protection businesses into two standalone companies.

Advance product innovation and regulatory approvalsMedium term

New seed traits and crop protection products drive pricing power and future growth, but require lengthy approvals.

Improve cost productivity and margin resilienceShort term

Higher volumes, raw material volatility and pricing pressure make operating efficiency critical to earnings stability.

Execute planned business separationMedium term

Splitting seed and crop protection could create more focused businesses and sharpen capital allocation.

Geography

2025

Corteva operates globally, with major exposure to North America, EMEA, Latin America and Asia Pacific. The company’s business is shaped by local regulatory approval processes, country-specific pesticide and biotechnology rules, and seasonal planting cycles that vary by region.

United States41 %
Latin America19 %
Europe, Middle East and Africa15 %
Brazil14 %
Asia Pacific6.6 %
Canada3.7 %

Share of the revenue the company reports by geography.

Risks

Corteva faces heavy regulatory and litigation risk because its products must be approved and periodically re-approved by agencies such as the EPA, USDA and FDA, and approvals can be delayed or restricted. The business is also exposed to weather, seasonality, input-cost swings, intellectual property disputes, counterfeit products and supply-chain disruption, all of which can affect demand, margins and product availability.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Regulatory approval delays and restrictions1Intellectual property infringement and counterfeit products2
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Regulatory approval delays and restrictionsImpact: HighLikelihood: High

    Seed traits and crop protection products require government approval and re-evaluation before sale.

    ExposureEPAUSDAFDAGlobal regulators
  2. Intellectual property infringement and counterfeit productsImpact: HighLikelihood: Low

    Biotech traits and branded agrochemicals are vulnerable to copying, theft and unauthorized use.

    Exposure: Seed traits and proprietary crop protection formulations

  3. Environmental and species-protection litigationImpact: High

    ESA and FIFRA challenges can force use restrictions, labeling changes or revocations.

    Exposure: Crop protection registrations

  4. Weather and seasonalityImpact: Medium

    Planting cycles and crop conditions drive quarterly demand and can shift revenue timing.

    ExposureNorth AmericaLatin AmericaOther seasonal markets
  5. Input-cost and supply-chain volatilityImpact: Medium

    Raw materials, manufacturing and logistics costs can move quickly and affect gross margin.

    Exposure: Global manufacturing and sourcing network

Accounting

Judgemental items
Restructuring and asset-related charges

These items are excluded from some non-GAAP measures and can materially affect period-to-period comparability.

Impact: Reported operating profit and adjusted EBITDA

Environmental remediation and legacy liabilities

PFAS and other legacy matters require accrual estimates and can change with new information.

Impact: Operating expenses, provisions and cash outflows

Seasonal working capital and short-term borrowings

Inventory build and receivables timing can drive debt balances and liquidity needs.

Impact: Balance sheet leverage and cash flow

Foreign currency and derivative accounting

Global operations create FX exposure and mark-to-market volatility in non-operating results.

Impact: Earnings volatility and hedging effectiveness

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Corteva, Inc. (CTVA) Revenue, Earnings & Financials 2025 – Clarifo